Literature DB >> 15316033

Macrophages from lupus-prone MRL mice are characterized by abnormalities in Rho activity, cytoskeletal organization, and adhesiveness to extracellular matrix proteins.

Angelika Longacre1, Jason S Koh, Kevin K-H Hsiao, Hannah Gilligan, Hanli Fan, Vimal A Patel, Jerrold S Levine.   

Abstract

Macrophages (mphi) from prediseased mice of the major murine models of lupus have an identical defect in cytokine expression that is triggered by serum and/or apoptotic cells. It is striking that cytokine expression in the absence of serum and apoptotic cells is equivalent to that of nonautoimmune mice. Here, we show that mphi from prediseased lupus-prone MRL/MpJ (MRL/+) or MRL/MpJ-Tnfrsf6(lpr) (MRL/lpr) mice also have reversible abnormalities in morphology, cytoskeletal organization, and adhesive properties. In the presence of serum, MRL mphi adhered in increased numbers to a variety of extracellular matrix proteins compared with mphi from two nonautoimmune strains. However, in the absence of serum, adhesion by MRL mphi was similar to that of nonautoimmune mphi. Increased adhesion by MRL mphi was also observed in the presence of apoptotic, but not necrotic, cells. The morphology and actin-staining pattern of adherent MRL mphi were consistent with reduced activity of Rho, a cytoskeletal regulator. Indeed, MRL mphi cultured in the presence of serum had markedly decreased levels of active Rho compared with nonautoimmune mphi. It is remarkable that when cultured in the absence of serum, MRL mphi displayed normal Rho activity and cytoskeletal morphology. Addition of a Rho inhibitor to normal mphi reproduced the morphologic and cytoskeletal abnormalities observed in MRL mphi. Taken together, our findings support the hypothesis that mphi from MRL and other systemic lupus erythematosus-prone mice have an apoptotic, cell-dependent, autoimmune phenotype that affects a broad range of mphi functions, including cytokine gene expression and Rho-dependent cytoskeletal regulation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15316033     DOI: 10.1189/jlb.0604346

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  6 in total

1.  Apoptotic cells, at all stages of the death process, trigger characteristic signaling events that are divergent from and dominant over those triggered by necrotic cells: Implications for the delayed clearance model of autoimmunity.

Authors:  Vimal A Patel; Angelika Longacre; Kevin Hsiao; Hanli Fan; Fanyong Meng; Justin E Mitchell; Joyce Rauch; David S Ucker; Jerrold S Levine
Journal:  J Biol Chem       Date:  2005-12-22       Impact factor: 5.157

Review 2.  The affirmative response of the innate immune system to apoptotic cells.

Authors:  Vimal A Patel; Angelika Longacre-Antoni; Marija Cvetanovic; Daniel J Lee; Lanfei Feng; Hanli Fan; Joyce Rauch; David S Ucker; Jerrold S Levine
Journal:  Autoimmunity       Date:  2007-06       Impact factor: 2.815

3.  Macrophages from lupus-prone MRL mice have a conditional signaling abnormality that leads to dysregulated expression of numerous genes.

Authors:  Angelika Antoni; Vimal A Patel; Hanli Fan; Daniel J Lee; Lee H Graham; Cristen L Rosch; Daniel S Spiegel; Joyce Rauch; Jerrold S Levine
Journal:  Immunogenetics       Date:  2011-01-13       Impact factor: 2.846

4.  Aberrant macrophages mediate defective kidney repair that triggers nephritis in lupus-susceptible mice.

Authors:  Yasunori Iwata; Elisabeth A Boström; Julia Menke; Whitney A Rabacal; Laurence Morel; Takashi Wada; Vicki R Kelley
Journal:  J Immunol       Date:  2012-03-30       Impact factor: 5.422

5.  Altered cell-cell and cell-matrix interactions in the development of systemic autoimmunity.

Authors:  Angelika Antoni; Lee H Graham; Joyce Rauch; Jerrold S Levine
Journal:  Autoimmunity       Date:  2009-05       Impact factor: 2.815

6.  mTORC2 Activity Disrupts Lysosome Acidification in Systemic Lupus Erythematosus by Impairing Caspase-1 Cleavage of Rab39a.

Authors:  Andrew J Monteith; Heather A Vincent; SunAh Kang; Patrick Li; Tauris M Claiborne; Zenon Rajfur; Ken Jacobson; Nathaniel J Moorman; Barbara J Vilen
Journal:  J Immunol       Date:  2018-06-04       Impact factor: 5.422

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.